Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 202

1.

Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?

Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Divers CH, Valderrama A, Freedland SJ.

Prostate Cancer Prostatic Dis. 2016 Jul 5. doi: 10.1038/pcan.2016.26. [Epub ahead of print]

PMID:
27377207
2.

Pathologic and Biochemical Outcomes among African-American and Caucasian Men with Low-Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.

Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR.

J Urol. 2016 Jun 25. pii: S0022-5347(16)30747-9. doi: 10.1016/j.juro.2016.06.086. [Epub ahead of print]

PMID:
27352635
3.

Effect of dietary omega-3 fatty acids on tumor-associated macrophages and prostate cancer progression.

Liang P, Henning SM, Schokrpur S, Wu L, Doan N, Said J, Grogan T, Elashoff D, Cohen P, Aronson WJ.

Prostate. 2016 Jun 24. doi: 10.1002/pros.23218. [Epub ahead of print]

PMID:
27338236
4.

Predictors of Time to Metastasis in Castration-Resistant Prostate Cancer.

Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Hanyok BT, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Liede A, Freedland SJ.

Urology. 2016 Jun 15. pii: S0090-4295(16)30294-1. doi: 10.1016/j.urology.2016.06.011. [Epub ahead of print]

PMID:
27318265
5.

Variations in payment patterns for surgical care in the centers for Medicare and Medicaid Services.

Bergman J, Laviana AA, Kwan L, Lerman SE, Aronson WJ, Bennett CJ, Hu JJ.

Surgery. 2016 Feb 25. pii: S0039-6060(16)00045-3. doi: 10.1016/j.surg.2015.12.028. [Epub ahead of print]

PMID:
26922367
6.

Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.

Allott EH, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):547-54. doi: 10.1158/1055-9965.EPI-15-0876. Epub 2016 Jan 25.

PMID:
26809276
7.

Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer.

Freedland SJ, Howard LE, Hanyok BT, Kadiyala VK, Kuang JY, Whitney CA, Wilks FR, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Aronson WJ, Moreira DM.

BJU Int. 2016 Jan 13. doi: 10.1111/bju.13405. [Epub ahead of print]

PMID:
26762961
8.

Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.

McGinley KF, Sun X, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ.

Int J Urol. 2016 Mar;23(3):241-6. doi: 10.1111/iju.13027. Epub 2015 Dec 14.

PMID:
26667212
9.

Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.

Hanyok BT, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Posadas EM, Freedland SJ.

Cancer. 2016 Jan 15;122(2):222-9. doi: 10.1002/cncr.29748. Epub 2015 Oct 20.

PMID:
26484853
10.

Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.

Klaassen Z, Howard L, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ.

Cancer Epidemiol. 2015 Dec;39(6):1066-70. doi: 10.1016/j.canep.2015.09.007. Epub 2015 Oct 6.

PMID:
26452418
11.

Do all men with pathological Gleason score 8-10 prostate cancer have poor outcomes? Results from the SEARCH database.

Fischer S, Lin D, Simon RM, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Vidal AC.

BJU Int. 2016 Aug;118(2):250-7. doi: 10.1111/bju.13319. Epub 2015 Oct 8.

PMID:
26351095
12.

Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer.

Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Hanyok BT, Pratson CL, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Liede A, Freedland SJ.

Prostate Cancer Prostatic Dis. 2015 Dec;18(4):333-7. doi: 10.1038/pcan.2015.25. Epub 2015 May 26.

13.

A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer.

Pantuck AJ, Pettaway CA, Dreicer R, Corman J, Katz A, Ho A, Aronson W, Clark W, Simmons G, Heber D.

Prostate Cancer Prostatic Dis. 2015 Sep;18(3):242-8. doi: 10.1038/pcan.2015.32. Epub 2015 Jul 14.

PMID:
26169045
14.

Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?

Simon RM, Howard LE, Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Vidal AC.

BJU Int. 2016 Jun;117(6):897-903. doi: 10.1111/bju.13182. Epub 2015 Jun 23.

PMID:
26010251
15.

Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.

Mithal P, Howard LE, Aronson WJ, Terris MK, Cooperberg MR, Kane CJ, Amling C, Freedland SJ.

BJU Int. 2016 Feb;117(2):244-8. doi: 10.1111/bju.13181. Epub 2015 Jun 23.

PMID:
26010160
16.

Agent Orange and long-term outcomes after radical prostatectomy.

Ovadia AE, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Abern MR.

Urol Oncol. 2015 Jul;33(7):329.e1-6. doi: 10.1016/j.urolonc.2015.04.012. Epub 2015 May 18.

PMID:
25998746
17.

Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.

Zapata DF, Howard LE, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Freedland SJ.

Int J Urol. 2015 Jul;22(7):658-62. doi: 10.1111/iju.12773. Epub 2015 Apr 14.

18.

Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.

Mithal P, Howard LE, Aronson WJ, Kane CJ, Cooperberg MR, Terris MK, Amling CL, Freedland SJ.

Int J Urol. 2015 Apr;22(4):362-6. doi: 10.1111/iju.12704. Epub 2015 Feb 24.

19.

Nutrition, dietary interventions and prostate cancer: the latest evidence.

Lin PH, Aronson W, Freedland SJ.

BMC Med. 2015 Jan 8;13:3. doi: 10.1186/s12916-014-0234-y. Review.

20.

Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.

Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D, Carpenter CL, Heber D, Aronson WJ.

Prostate. 2015 Apr 1;75(5):550-9. doi: 10.1002/pros.22943. Epub 2014 Dec 24.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk